Atossa Therapeutics, Inc.

Historical 13F Holders

Symbol
ATOS
CUSIP
04962H506
All holders as of
Q3 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q3 75 19.5 M $16.9 M
2025 Q2 89 21.4 M $17.7 M
2025 Q1 89 28.4 M $19.1 M
2024 Q4 91 29.9 M $28.2 M
2024 Q3 94 27.5 M $41.7 M
2024 Q2 86 26.7 M $31.8 M
2024 Q1 76 20.8 M $37.4 M
2023 Q4 56 16.1 M $14.2 M
2023 Q3 62 16.2 M $11.9 M
2023 Q2 58 16.0 M $20.1 M
2023 Q1 52 16.4 M $11.9 M
2022 Q4 63 18.4 M $9.75 M
2022 Q3 68 19.0 M $15.8 M
2022 Q2 82 23.3 M $25.4 M
2022 Q1 95 35.9 M $45.5 M
2021 Q4 114 39.5 M $64.2 M
2021 Q3 113 31.1 M $102 M
2021 Q2 113 35.7 M $226 M
2021 Q1 70 10.8 M $22.8 M
2020 Q4 29 1.69 M $1.61 M
2020 Q3 29 739 k $1.79 M
2020 Q2 18 312 k $1.18 M
2020 Q1 12 242 k $322 k
2019 Q4 17 391 k $612 k
2019 Q3 17 262 k $513 k
2019 Q2 16 255 k $649 k
2019 Q1 15 308 k $765 k
2018 Q4 20 798 k $814 k
2018 Q3 18 568 k $991 k
2018 Q2 16 536 k $1.18 M